Evidence map›Paper›PMID 41853433›Full record

ArticleCureus2026

Evaluation of a Simplified Technique for the Excision of Non-palpable Breast Cancer.

Aya M Alamrawy, Mohamed Alatrash, Lamiaa Adel, Emad Khallaf

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aya M AlamrawyGeneral Surgery, Cairo University, Cairo, EGY.
Mohamed AlatrashGeneral Surgery, Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, GBR.
Lamiaa AdelRadiology, Cairo University, Giza, EGY.
Emad KhallafSurgery, Cairo University, Giza, EGY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common malignancy and the leading cause of cancer-related mortality among women, with early detection through screening programs significantly improving survival rates and reducing mortality. Accurate localization and excision of early-stage non-palpable lesions minimize the need for re-excision, prevent unnecessary removal of breast tissue, and improve cosmetic outcomes. This study aimed to optimize the wire localization technique for the excision of non-palpable breast cancer. A total of 46 female patients referred to the breast unit at Kasr Al-Ainy, Cairo University, underwent wire localization excision, with wire insertion performed one day before surgery. Modifications to the localization process included optimized timing of wire insertion, enhanced radiology reporting with diagrams indicating wire distance, direction (clockwise orientation), and orthogonal mapping, as well as placement of a skin mark over the lesion site. In some cases, aqueous carbon suspension was used to improve intraoperative visualization. The incision was made near the skin site corresponding to the lesion, flaps were raised, and the wire was retracted within the wound, followed by dissection along its path with a cuff of normal tissue to ensure adequate margins. The re-excision rate was minimal and was all due to ductal carcinoma in situ at the margins. This study demonstrated that the simplified excision technique was safe, reproducible, and effective for the management of non-palpable breast cancers, offering a reliable and reproducible orthogonal map, which was found to help with minimizing the re-excision rate without any additional resources.

Indexed as

non-palpable breast cancerorthogonal mappingre-excision ratesurgical resection with an adequate marginwire-guided localization

Identifiers

PMID41853433
PMCPMC12991902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.